U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards
The Early-stage FY 2024 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards invite binational or multinational teams to pursue cutting-edge studies in infectious diseases and immunology, with joint funding from AMED (Japan) and NIAID (USA).
Key Information:
-
R&D Phases: Basic, Applied, Nonclinical/Pre-clinical, Clinical Research
-
Research Areas: Infectious Diseases & Immunology; Project for Seeds Development & Research Base
-
Award Size: USD 60 000 per project, disbursed 50 % in JFY 2024 and 50 % in JFY 2025
-
Research Period: JFY 2024–JFY 2025
-
Expected Awards: 4–6 projects
Eligibility:
-
Collaborative teams with investigators from:
-
Japan + USA, or
-
Japan + USA + other Asia-Pacific country(ies)
-
-
Each application must designate both a Japanese sub-team PI and a U.S. sub-team PI who is an early-stage or female investigator
-
Host institutions in Japan must contract via AMED and meet AMED’s terms & conditions
How to Apply:
-
Title & Abstract: Email [email protected] by May 20, 2024 (replace “AT” with “@”).
-
Full Proposal: Submit through CRDF Global’s portal by June 3, 2024.
-
Japanese Sub-team: Complete e-Rad registration by June 5, 2024.
-
Follow formats and guidelines in the Request for Proposals and AMED Supplemental Application Guideline (Japanese).
Contact:
AMED, Dept. of International Strategy, Division of Research Programs
Tel: +81-3-6870-2216
Email: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023